Receptor 接受器or受器
Intracellular receptor
Intercellular signaling in animals by receptors
1. Trimeric G protein-linked receptors (GPCR) (e.g. glucagon-, serotonin- adrenalin-receptors) 2. Ion-channel receptors (ligand-gated ion-channels, e.g. the acetylcholine receptor) iontropic receptor
3. Receptors3. Receptors lacking
lackingintrinsic catalytic activityintrinsic catalytic activity
butbut directly directly
associated with cytosolicassociated with cytosolic protein tyrosine kinases
proteintyrosine kinases 4. Receptors with intrinsic enzymatic activity
(e.g. guanylate cyclase activity, protein phosphatase, serine/threonine kinase or tyrosine kinase activity) 5. Cell adhesion molecules
6. Intracellular receptors
Two classes of receptors have two basic structural plans in cell membrane:
G-protein coupled receptor Tyrosine kinase linked receptor Instrinsic enzymatic receptor
Ionotropic Metabotropic
1. Ligand-gated ion channels (ionotropic) exist in cell membrane. e.g. nAChR 2. G-protein coupled receptors
(metabotropic) exist in cell membrane e.g. mAChR 3. Tyrosine Kinase linked
Receptor exist in cell membrane e.g. cytokine receptors
4. Instrinsic emzymatic receptor. Receptor Tyrosine kinase (RTK) can
autophosphorylation.
All receptors are proteins made up of varying numbers of subunits or transmembrane domains.
Four classes of cell-surface receptors Cell-surface receptors belong to four major classes
GPCRs are involved in a range of signaling pathways, including light detection, odorant detection, and detection of certain hormones and neurotransmitters
Many different mammalian cell-surface receptors including GPCRs are coupled to a trimeric signal-transducing G protein
– made of an alpha, beta and gamma subunit complex Ligand binding activates the receptor, which activates the G protein,
which activates an effector enzyme to generate an intracellular second messenger
– e.g. adenylyl cyclase – converts ATP to cAMP depending on regulation at the effector enzyme – this pathway can
be either activated or inhibited
– by the type of G protein activated by the hormone-receptor complex
– Gs proteins result in stimulationof the effector enzyme – Gi proteins result ininhibitionof the effector enzyme
adenylyl cyclase (AC)
Four classes of cell-surface receptors
-ligand binding changes the confirmationof the receptor so that specific ions flow through it the resultant ion movement alters the electric potentialacross the plasma membrane
-found in high numbers on neuronal plasma membranes e.g. ligand-gated channels for sodium and potassium -also found on the plasma membrane of muscle cells
-binding of acetylcholine results in ion movement and eventual contraction of muscle
-lack intrinsic catalytic activity
-binding of the ligand results in the formation of a receptor dimer (2 receptors) -this dimer than activates a class of protein called tyrosine kinases
-this activation results in the phosphorylation of downstream targets by these tyrosine kinases (stick phosphate groups onto tyrosines within the target protein)
-receptors for cytokines such as, interferons
NO-self enzymatic activity
-also called receptor tyrosine kinases OR ligand-triggered protein kinases -similar to tyrosine-linked receptors - ligand binding results in formation of a dimer -BUT: they differ from tyrosine-linked receptors – intrinsic catalytic activity
-means that ligand binding activates it and the activated receptor acts as a kinase
-recognize soluble or membrane bound peptide/protein hormones that act as growth factors
e.g. NGF, PDGF, insulin
-binding of the ligand stimulates the receptor’s tyrosine kinase activity,
-results in phosphorylation of multiple amino acid residues within its target such as serine and threonine residues
-this phosphorylation activates downstream targets
-its targets are generally other protein kinases –which phosphorylate their own downstream targets (other kinases??)
Signal transduction Cascade
Itself enzymatic activity
Itself enzymatic activity
Itself enzymatic activity
Itself enzymatic activity NO-self enzymatic activity Itself enzymatic activity
NO-self enzymatic activity
Cell adhesion molecular
Nucleus or cytoplasmic receptor
estrogen receptor 類酯醇X受體(Pregnane X receptor PXR
G-protein coupled receptors (GPCRs)
Ligand binding activates a G-protein which in turn activates or inhibits an enzyme that generates a specific second messenger
Four classes of cell-surface receptors
How G proteins were discovered
Gilman & Ross studying connection between adrenalin receptors and the enzyme adenylate cyclase which makes cyclic AMP
ATP adenylate cyclase cAMP
used a mutant cell line cyc
-that bound adrenalin but appeared to lack adenylate cyclase lucky experiment that led to the Nobel prize!!
cyc
-adrenalin Expt 1
no cAMP
cyc-
+ wild-type extract
(untreated)
adrenalin Expt 2
cAMP
adrenalin
cyc-+
wild-type extract (AC inactivated)
Expt 2
cAMP !?
Explanation: cyc
-cells didn’t lack adenylate cyclase, but lacked another factor (G proteins) that activates adenylate cyclase
Cyc
-mutant ? Not without adenylate cyclase →without some thing
把野生種萃取物中AC抑 制掉,但還是有反應?顯示 是cyc-還是有自己的AC 活性所致, 所以是以前 cyc-對的認知有錯誤,是 少某種物質而非AC 可能野生種的
AC所導致 cAMP增加
The importance of G-proteins
The Nobel Prize in Physiology and Medicine 1994
Alfred G. Gilman Martin Rodbell
USA USA
1941- 1925-1998
"for their discovery of G-proteinsand the role of these proteins in signal transduction in cells"
G-protein linked receptors most common type of receptor
when receptor is activated by stimulus operates via an intermediary – G protein (guanine nucleotide binding protein)
G protein in turn regulates enzyme or ion channel
all G-protein coupled receptors have 7 transmembrane spanning regions A major target for drug e.g. beta blockers, antihistamines
Most act via hetero-trimeric G-proteins with cAMP, cGMP and PLC often being used as downstream effectors
Receptors downregulated following ligand activation to assist with shutoff of the switch
Nearly 2500 GPCRs have been identified
Bovine rhodopsin was cloned in 1983 (Nathans and Hogness); - adrenergic receptor in 1986 (Dixon et al.)
General structure:
N-terminalsegment: glycosylation, ligand binding (outer) C-terminalsegment: phosphorylation and palmitoylation (inner) Seven transmembrane domain (TMs): form six loops (three exoloops and three-four cytoloops) and a TM core that could provide ligand specificity and regulatory mechanism
Largest class of cell surface Receptors
All have a structure with seven transmembranealpha helical Loops
Orientation is always conserved with N terminus outside, C terminus insidethe cell and cytosolic segments interacting with G proteins
Sequences at C3, C4 and sometimes C2 determine which G protein is activated Genome sequencing has revealed more new members
Half of all known drugs bind to G protein-linked receptors
Membrane bound effector proteins
Effector proteins are then capable of amplifying the signals that will then be further transduced to secondary targets. Examples:
– Adenylyl cyclase (cAMP synthesis)
– Phospholipase Cβ (inositol lipid release from membrane)
– Phospholipase A2 (arachidonic acid release from membrane, precursor of prostaglandin and leukotriene synthesis)
– Guanylyl cyclase (cGMP synthesis)
– Cyclic nucleotide phosphodiesterase (breakdown of cGMP and cAMP)
– Potassium and calcium ion channels Gsα stimulates adenylyl cyclase GTP bound Gsα interacts with adenylyl cyclase
The structural changes that are induced are not known, but the result is active enzyme
Many signals, through different receptors, can activate Gsα, resulting in a higher concentration of GTPGsα and the production of higher levels of cAMP
Forskolin, applied to cells, will activate pathways mediated by cAMP adenylyl cyclase activator
GPCRs
Illustration of the central core of rhodopsin. The core is viewed from the cytoplasm.
-Among membrane-bound receptors, the G protein-coupled receptors (GPCRs) are the most diverse.
-In vertebrates, this family contains 1000 – 2000 members (>1% of the genome).
-GPCRs have been very successful during evolution, being capable of transducing messages as different as photons, organic odorants, necleotides, peptides, lipids and proteins.
-GPCRs have a common ”central core”, composed of 7 transmembrane helical domains.
-The fine-tuning of coupling of the receptor to G proteins is regulated by splicing, RNA editing and phosphorylation.
(A) GPCRs have a central commoncore made of seven transmembrane helices(TM-I to -VII) connected by three intracellular(i1, i2, i3) and three extracellular(e1, e2, e3) loops.
The diversity of messages which activate those receptors is an illustration of their evolutionary success. (B) Illustration of the central core of rhodopsin. The core is viewed from the The core is viewed from the cytoplasm
cytoplasm. The length and orientation of the TMs are deduced from the two-dimensional crystal of bovine and frog rhodopsin (Unger et al., 1997). The N- and C-terminal of i2 (including the DRY sequence) and i3 are included in TM-III and -VI. The core is represented under its 'active conformation'.
The TM-VI and -VII lean out of the structure, the TM-VI turn by 30% on its axis (clockwise as viewed from the cytoplasm) (Bourne, 1997). This opens a cleft in the central core in which G proteins can find their way. i2 and i3 loops are the two main loops engaged in G protein recognition and activation.
EMBO J. 18: 1723-1729 (1999) GPCR encoded for >1000 genes, represent app.1% of human gemone
1. G protein is an trimeric protein which binds guanine nucleotides.
2. They function to couple integral membrane receptors to target membrane-bound enzymes.
3. They can be considered molecular switches wherein…
GDP(inactive)
GTP(active) +
4. The dissociated subunit expresses GTPase activity.
Characteristics of G proteins
5. GTPS blocks GTPase activity of GTP.
GPCRs
Nature Reviews Molecular Cell Biology 3; 639-650 Receptor activation…
GPCRs activate different sub-classes of heterotrimeric G-proteins and effector systems (cont’d)
Heterotrimeric G-proteins
Highly conserved mechanismlinking to most GPCR’s
Following activation of GPCR the GDP on G( heterotrimeric G- protein is switched for GTP causing dissociation to G and G after stimulation. Both can have signalling effects
G Over 20 forms have now been identified in mammals. Divided into Gs which generally activate effector, Gi which generally inhibitory, Gq which generally act via phospholipases. The GTPase activity acts as a time dependent switch by converting GTP to GDP
G About 6 forms of and 12 forms of have now been identified. The G stay as dimer and can regulate molecules including K+channels and PI 3-kinases
Receptors cycle between resting and active states
G proteins are activated in response to binding by an activated receptor
GTP displaces GDP and subunits dissociate. Gα is activated
General Themes in Heterotrimeric G protein Pathways
Rockman H.A. et al (2002) Nature 415:206
May be > 20
Basic structure/function of G-protein subunits:
heterotrimers consist of one copy of alpha (39-45kDa), beta (35-36kDa) and gamma (5-7kDa) subunits
The tools for G-protein receptor signal transduction research
So, inhibitory signal ↓ So, stimulatory signal ↑
G-protein ADP ribosylation
+ Gs
Bacterial toxin (PTX, CTX) Nicotinamide
ADP-ribose G
GTPase
CTX: for Gs
PTX: for Gi
85 kDa
Family 1 contains most GPCRs including receptors for odorants (氣 味), small ligands, peptide hormone and glycoprotein. Disulphide bridge connects e1 and e2 and palmitoylated cysteine in C-terminal.
Family 2 GPCRs have relative long N- terminal that contains several cysteines (network of disulphide bridge). Examples include glucagon, GnRH and PTH receptors.
Family 3 GPCRs have very large span N-terminal sequences and C-terminal tail. The ligand binding domain is located in the N-treminus. The i3 loop is short and highly conserved.
Representative samples are mGluR, Ca2+-sensing and GABA-B receptor.
The three subfamilies of GPCRs are depicted with examples of their endogenous agonists.
The binding modes of the orthosteric (直立) ligands for each receptor type are depicted by a green rectangle. The GPCR signals either by coupling to heterotrimeric G- proteins consisting of and subunits (which trigger a wide range of metabolic cascades and ion channel activities) or by direct association with effector molecules. AC, adenylyl cyclase; ATP, adenosine triphosphate;
cAMP, cyclic adenosine monophosphate; PLC, phospholipase C; IP3, inositol-3,4,5-tris- phosphate; DAG, diacylglycerol.
Functional regions within GPCRs: G-protein interacting domains & ligand binding domain
一種味覺
Schematic presentation of the general structure of Schematic presentation of the general structure of GPCRsGPCRs
and receptor
and receptor--ligandligandinteractionsinteractions
J Biol Chem 273:17299-17302,1998 Platelet aggregation
1. Proteinase-activated receptor ( PAR ) Family PAR1~4
2. PAR2’s activation induces acute inflammation
Ligand Binding and GPCR Activation
• Modes of ligand binding:
Exclusive in TM core: photon, biogenic amines, nucleotides and lipid substrates (B)
core, exoloops and N-terminal segment: peptides of ≤40 amino acids (C)
N-terminal segment cleavage: protease( thrombin) (D) N-terminal segment and exoloops: glycoprotein hormone
( approximately 350 amino acids) (E)
N-terminal segment (~600 amino acids): calcium channel, GABA and metabotropic receptor (F)
The G subunit of G protein cycles between active and inactive forms
Receptor mediated activation of coupled G-proteins occurs within a few seconds of ligand in living cells
FRET
Fluorescence resonance energy transfer
Applications for monitoring molecular interactions in Living cells by FRET
Monitor protein-protein interaction Monitor intramolecular conformational change
Calcium sensor
M13, a peptide binds to calmodulin in
Kinase activation sensor
Receptor activation…
GPCRs activate different sub-classes of heterotrimeric G-proteins and effector systems
GPCR
↓ Second messenger
↓ effector
↓ response
GRK: G-protein coupled receptor kinase
triglyceride breakdown adrenaline, ACTH, glucagon,
TSH Fat
water resorption vasopressin
Kidney
glycogen breakdown glucagon
Liver
increase in heart rate and force of contraction
adrenaline Heart
bone resorption parathormone
Bone
glycogen breakdown adrenaline
Muscle
progesterone secretion luteinizing hormone (LH)
Ovary
cortisol secretion adrenocorticotrophic hormone
(ACTH) Adrenal cortex
thyroid hormone synthesis and secretion
thyroid-stimulating hormone (TSH)
Thyroid gland
MAJOR RESPONSE HORMONE
TARGET TISSUE
aggregation thrombin
Blood platelets
contraction acetylcholine
Smooth muscle
amylase secretion acetylcholine
Pancreas
glycogen breakdown vasopressin
Liver
MAJOR RESPONSE SIGNALING MOLECULE
TARGET TISSUE
Diversity(of physiological responses to GPCR stimulation)
AC: adenylyl cyclase PDE: phosphodiesterase PLC: phospholipase C
Complexity of GPCR signalling Cascades
Multiple physiological responses GPCRs cross talk with Receptor Tyrosine Kinases (RTK)
Given such a diversity in responses, how does GPCR signaling specificity occur???
GPCR vs. RTK
Turn off of the signal from GPCR
The mechanisms regulate (terminate) signaling form GPCR
1.GTP → GDP (exchange)
2. Degradation of second message, cAMP phosphodiesterase (cAMP →5’AMP) or cGMP phosphodiesterase…
3.Receptor phophorylation by down stream signal (cAMP → PKA
→ phosphorylation of receptor); feedback regulation (Desentization; heterologus or homologous)
4. Protein Phosphatase catalyzes removal by hydrolysis of phosphates that were attached to proteins via Protein Kinase A Agonist or antagonist → receptor → activation of receptor specific enzyme (receptor kinase) → phosphorylation; directly from receptor action is called homologus desentization
Phosphodiesterase enzymes catalyze:
cAMP + H
2O AMP The phosphodiesterase that cleaves cAMP is activated by phosphorylation catalyzed by Protein Kinase A.
Thus cAMP stimulates its own degradation, leading to rapid turnoff of a cAMP signal.
N
N N
N NH2
O
O OH H H
H H2
C O H
P
O O-
1' 3'
5' 4'
2'
cAMP
Anchoring proteins
localize effects of cAMP to specific subcellular regions
(new model for turn off signal from GPCR)
PDE:phosphodiesterase, cAMP →5’AMP AKPA: ANCHORING PROTEIN
In heart muscle: adrenergic receptor → cAMP ↑→ activate PKA → C, catalytic region → phosphorylate → PDE → activation → degradation of cAMP
AKAPs
(A-Kinase Anchoring Proteins) are scaffold
proteinswith multiple domains that bind to
regulatory subunits of Protein Kinase A
phosphorylated
derivatives of phosphatidylinositol
various other signal proteins, such as:
•
G-protein-coupled receptors (GPCRs)
•
Other kinases such as Protein Kinase C
•
Protein phosphatases
•
Phosphodiesterases
AKAPs localize
hormone-initiated signal cascades within a cell, and coordinate activation of protein kinases as well as rapid
turn-offof such signals.
Receptor desensitization occurs. This process varies with the hormone.
Some receptors are phosphorylated via specific receptor kinases.
The phosphorylated receptor may then bind to a protein
arrestin, that promotes removal of the receptorfrom the membrane by clathrin-mediated endocytosis.
First discovery: -adrenergic receptor
Heterologous desensitization:
– Four residues in the cytosolic domain of the - adrenergic receptor can be phosphorylated by PKA – Activity of all Gs protein – coupled receptors, not just
the -adrenergic receptor, is reduced
Homologous desensitization:
– Other residues in the cytosolic domain of the -
adrenergic receptor are phosphorylated by the receptor- specific -adrenergic receptor kinase (BARK)
– BARK only phosphorylates the -adrenergic receptor which facilitates -arrestin binding to the phosphorylated receptor
– Related with GRK (G-protein receptor kinase
Hormonally induced negative regulation of receptors is referred to as homologous- desensitization
This homeostatic mechanism protectsfrom toxic effects of hormone excess.
Heterologous desensitization occurs when exposure of the cell to one agonist reduces the responsiveness of the cell any other agonist that acts through a different receptor.
This most commonly occurs through receptors that act through the adenylyl cyclase system.
Heterologous desensitization results in a broad pattern of refractoriness with slower onset than homologous
desensitization
G protein-coupled receptor kinases (GRKs)
A family of serine-threonine kinases that recognizes and phosphorylates receptors in their agonist-stimulated form
Consensus sequence:
serine/threonine residues surrounded by acidic residues DLEESSSSD
Receptor phosphorylation by second messenger kinases
Receptor phosphorylation by GRKs
Heterologous desensitization
homologous-desensitization GRK: G-protein
receptor kinase
GRK Tissue expression Regulation
GRK1 (rhodopsinkinase) Retinal rods and cones Farnesylation of C terminus GRK2 (ARK1) Ubiquitous, brain PIP2and G binding GRK3 (ARK2) Ubiquitous, in the brain PIP2and G binding
is lower than GRK2
GRK4 Testes; low in brain PIP2-binding through polybasic C ter minus domains and palmitoylated cysteine residues
GRK5 Ubiquitous, brain Modulated by CAM and calcium sen
sor proteins
GRK6 Ubiquitous, brain palmitoylated cysteine residues
GRK7 Retinal cones Geranygeranylated
Members of the GRK family and their regulation
GRK: G-protein coupled receptor kinase 到處存在
Regulation of GRK function
Penela P, Ribas C, Mayor F. Jr. Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. Cell Signal. 2003 Nov;15(11):973-981.
Desensitization or Endocytosis of GPCR’s Effected by Phosphorylation
1. The ligand activated receptor can be phosphorylated on select Ser/Thr residues by GRK (e.g. BARK - adrenergic receptor kinase). These phosphorylated residues provide a docking site for arrestin resulting in inactivation/desensitization.
2. In some instances, arrestin binding targets the receptor for clathrin-dependent endocytosis.
3. In addition, if the occupied GPCR leads to cAMP, the receptor can also be phosphorylated by PKA leading to its inactivation/densensitization.
-Arrestins : intracellular protein
- Interaction with phosphorylated GPCRs uncouples the receptors from
heterotrimeric G proteins, producing a nonsignaling, desensitized receptor. (desensitization )
- Target the GPCRs to clathrin-coated pits for endcytosis to function as docking proteins that link receptors to components of the endocytic machinery such as AP-2 and clathrin (internalization )
- Regulate the dephosphorylation of Receptors (resensitization).
The ability of -Arrestins to remain associated with some receptors but not others suggests that -Arrestins may regulate the cellular trafficking and dephosphorylation of receptor and ultimately their kinetics of resensitization.
Clathrin-dependent Receptor-mediated endocytosis
Ref. Seminars in Cell & Developmental biology 9,1998 Agonist binding
GRK-phosphorylation/
arrestin binding : uncouling,
desensitization Clathrin coated pit :
pinch off –dynamin - sequestration
?
Receptor Down-Regulation
Slower onset (hours to days), more prolonged effect Decreased synthesis of receptor proteins
Increase in receptor internalization and degradation
Internalization involves endocytosis of receptor: the endocytic vesicle may ultimately return the receptor to the cell surface, or alternatively may deliver the receptor to a lysosome for destruction.
Endocytic vesicles are associated with phosphatases which can clear phosphate from a receptor and ready it for reuse before returning it to the plasma membrane.
-lack intrinsic catalytic activity
-binding of the ligand results in the formation of a receptor dimer (2 receptors) -this dimer than activates a class of protein called tyrosine kinases
-this activation results in the phosphorylation of downstream targets by these tyrosine kinases (stick phosphate groups onto tyrosines within the target protein)
-receptors for cytokines such as, interferons
NO-self enzymatic activity
Two types of intracellular signaling complexes
Adapter protein: directly contact with receptor
Cytokine receptor
G protein-coupled receptors transmit signals to MAP kinase
Activated G of G- protein May also InduceMAPK Cascade Scaffold protein All MAP kinase are serine/threonine kinase
All molecule attached at scaffold protein
Two types of intracellular signaling complexes Tyrosine kinase receptors
One protein → phosphorylation → induced another protein bind → induced another protein
Cytokine receptors signal to the nucleus in a direct
pathway
Signaling pathway using modular binding domains
Adapter protein: directly contact with receptor; It also signal players
Signal protein complexes (more efficiency and specific)
Signal cascades are often mediated by large "solid state" assemblies thatmay include receptors, effectors, and regulatory proteins, linked together in part by interactions with specialized scaffold proteins.
Scaffold proteins often interact also with membrane constituents, elements of the cytoskeleton, and adaptors mediating recruitment into clathrin-coated vesicles.
They improve efficiency of signal transfer, facilitate interactions among different signal pathways, and control localization of signal proteins within a cell.
One strategy the cell uses to achieve specificity involves scaffolding proteins They organize groups of interacting signaling proteins into signaling
complexes
Because the scaffold guides the interactions between the successive components in such a complex, the signal is relayed with speed In addition, cross-talk between signaling pathways is avoided
Signal
molecule Plasma
membrane
Receptor
Scaffolding protein
Three different protein kinases
Scaffolding proteins are large relay proteins to which other relay proteins are attached
Scaffolding proteins can increase the signal transduction efficiency
Some receptors and signal transduction protein are localized
Synaptic junction: chemical signal → presynaptic cell → clustering receptor → raid and efficient signal transmission
PDZ: 90 a.a.; target protein Ser-Thr-X-Φ; X: any, Φ: hydorphobic PDZ interact with subunit receptor formed complex
Clustering of membrane proteins mediated by adapter domains
Protein motifes
(1) Mediate protein-protein interactions (2) Determine the location of signaling proteins
Src tyrosine kinase contains 4 functional regions (known function and by homologies with domains in other proteins).
The Src Homology (SH) domains have subsequently been defined as -SH1 being the Tyrosine Kinase -SH2 being a domain that binds phosphorylated tyrosines (or PTB) -SH3 being a domain that binds proline rich regions
-SH4 being a domain that regulated addition of lipids
Thus the domains contain not just enzyme activities but control the formation of protein complexes and anchoring to membranes
SH2 PH
signal
receptor
SH3 PPP
PLipid eg PIP3
P P YP
Tyr K
effects
Signal Transduction DomainsRelay(接替) proteins: pass the message to the next signaling component Adaptor proteins: link one signaling protein to another without themselves participating in the signaling event
Amplifier proteins: usually either enzymes or ion channels that enhance the signal they receive
Transducer proteins: convert the signal to a different form e.g. adenyl cyclase Bifurcation (分枝)proteins: spread the signal from one signaling pathway to another
Different kinds of intracellular signaling proteins along a signaling pathway from the cell surface to the nucleus
Ligand binding to the receptor activates an intrinsic enzymatic activity
Receptors with intrinsic enzymatic activity (e.g. guanylate cyclase activity, protein phosphatase, serine/threonine kinase or tyrosine kinase activity)
Tyrosine kinase receptors
these receptors traverse the membrane only once receptor has intrinsic enzyme activity– i.e. the receptor itself is an enzyme respond exclusively to protein stimuli
– cytokines
– mitogenic growth factors:
• platelet derived growth factor
• epidermal growth factor
These usually receive signals that regulate: cell proliferation (growth factors) or cell differentiation (inducers)
Tyrosine kinase activation is key event in intracellular signal transduction.
Most Tyrosine Kinase Receptors exist as inactive monomers in membrane.
Receptor autophosphorylation occurs via a ligand-induced receptor dimerization
Phosphotyrosine residues in cytoplasmic domain of receptor act as docking sites that bind cytoplasmic signaling molecules.
Tyrosine kinase:
(phosphorylation & dephosphorylation) kinase enzymes add a phosphate (Pi) group tyrosine kinase speicfically to tyrosine residue phosphatases remove Pi
phosphorylation state alters shape (conformation) of protein and changes its function
– enzyme activity; solute transport; gene expression
covalent modification by phosphorylation is extremely important in regulation biological responses
There are six major families of receptor tyrosine kinases.
All have a TK domain on the cytosolic, COOH-terminal end, A single-pass transmembrane domain, and
One or more cysteine-rich or Immunoglobuliu-like ligand-binding domains.
• An individual tyrosine-kinase receptor consists of several parts:
– an extracellular signal-binding sites, – a single alpha helix spanning the
membrane, and – an intracellular tail with several tyrosines.
• When ligands bind to two receptor polypeptides, the polypeptides aggregate, forming a dimer.
• This activates the tyrosine-kinase section of both.
• These add phosphates to the tyrosine tails of the other polypeptide.
• The fully-activated receptor proteins activate a variety of specific relay proteins that bind to specific phosphorylated tyrosine molecules.
– One tyrosine-kinase receptor dimer may activate ten or more different intracellular proteins simultaneously.
• These activated relay proteins trigger many different transduction pathways and responses.
Tyrosine Kinase Receptors
Note steps involved:
1. Ligand Reception 2. Receptor Dimerization 3. Catalysis (Phosphorylization) 4. Subsequent Protein Activation 5. Further Transduction
6. Response
Tyrosine Kinase Receptors
The TGFβ superfamily consists of many members.
Bone morphogenetic proteins (BMP) is the largest family.
TGFβ is formed by cleavage of a secreted inactive precursor
During development, TGFβ signaling is involved in pattern formation, cell proliferation, differentiation, ECM production, and cell death.
In adults, TGFβ is involved in tissue repair and immune regulation.
Maturation of TGFβ is dependent on release from LTBP (latent TGF- – binding protein) by proteolysis.
潛在
TGFR: receptor serine/
threonine kinase Smad: transcription factor TFE: transcription factor
phosphorylation
TGF- receptor and the direct activation of Smads
RII receptor has a constitutiveser/thr kinase activity TGFβ binding induces complex
formation between RII and RI;
phosphorylation of RI by RII activates RI kinase activity RI did not bind to TGF RI kinases Smad transcription
factors. Phosphorylation results in a conformational change in Smad Complexes with other transcriptional
factor = Smad4 Complex moves in nucleus Activates gene
Gene = plasminogen activator inhibitor no cell growth
kidney intestinal epithelial cells Membrane Form of Guanylyl Cyclase
1. Receptor guanylyl cyclases generate cGMPdirectly as an intracellular mediator
2. Atrial natriuretic peptides (ANPs) are family of related peptide hormones
3. Single pass
transmembrane protein that has extracellular binding site for ANPs and an intracellular guanylyl cyclase catalytic unit.
4. Binding of ANP activates cylase to produce cGMP which in turn activates cGMP- dependent protein kinase (G-
Kinase) GTP cGMP
Atrial natriuretic factor
Small hydrophobic signaling molecules, such as steroids, can cross the cell membrane (e.g. estrogen, vitamin D, thyroid hormone, retinoic acid) and bind to intracellular receptors
The hormone-receptor complex has an exposed DNA binding siteand can activate transcription directly (or, more typically as a homo- or hetero-dimer) This usually initiates a cascade of
transcription events
Intracellular receptors (nucleus receptor)
Nuclear Receptors
Lipid soluble ligands that penetrate cell membrane (corticosteroids, mineralocorticoids, sex steroids, Vitamin D, thyroid hormone) Receptors contain DNA-binding domains and act as ligand-regulated
transcriptional activators or suppressors(=> characteristic lag period of 30 minutes to several hours):
Ligand binding of the receptors triggers the formation of a dimeric complexthat can interact with specific DNA sequences (=“Response Elements”) to induce transcription. The resulting protein products possess half-lifes that are significantly longer than those of other signaling intermediates => Effects of nuclear receptor agonists can persist for hours or daysafter plasma concentration is zero.
response
Some signaling molecules that bind to intracellular receptors
cortisol
thyroxine
estradiol testosterone
Vitamin D3
Retinoic acid 一種腎上腺
皮質內泌素
雌二酮 睪固酮
甲狀腺素
維他命A酸
Nuclear Receptors
• Examples:
– Glucocorticoids: Inhibit transcription of COX-2; induce transcription of Lipocortin
– Mineralcorticoids: Regulate expression of proteins involved in renal function
– Retinoids (Vit A derivatives): Control embryonic development of limbs and organs; affect epidermal differentiation => dermatological use (Acne)痤瘡 粉刺
– PPARs(Peroxisome Proliferation-Activated Receptors): control metabolic processes:
• PPAR: Target of Fibrates (cholesterol lowering drugs: stimulate
-oxidation of fatty acids)
• PPAR: Target of Glitazones (anti-diabetic drugs: induce expression of proteins involved in insulin signaling => improved glucose uptake)
The nuclear receptor superfamily
Hinge 鉸縺
Nuclear Receptor Family
is Large but not ubiquitous:
mammals have ~50-60 genes flies 21
worms 270 (!!!) plants 0
yeast 0
Only a handful of physiological ligands have been identified,
(despite many genes, worms lack any known lipid based endocrine system)
Steroid hormone receptors are part of the superfamily of nuclear receptors that contains over 30 members.
All members have conserved regions of high homology Hormone binding domain 90% homologous
10% difference accounts for specificity
DNA binding domain which contains zinc fingers
Receptors are found complexed with heat shock proteins (HSP) Unoccupied receptor held in inactive conformation by HSP Ligand binding releases HSP and exposes DNA binding domain Hormone receptor complex then binds to response elements on
gene and allows transcription to occur
Nuclear receptor family (steroid)
Early primary response (A) and delayed secondary response (B) that result from the activation
of an intracellular receptor protein
Ligand gate Ion-channel receptors
Ligand binding changes the conformation of the
receptor so that specific ions flow through it
Types of Membrane Ionic Channels
Non-gated channels: leakage channels open at rest
Gated Channels:
– Voltage-gated channels – Mechanically-gated channels
– Chemically-gated channels (from outside or inside of the membrane)
• Neurotransmitter-activated
• Calcium-gated
• ATP-gated
• Cyclic nucleotide-gated
• About 100 different kinds of channels
Nongated
ion channels and the resting membrane potential
Gated: need ligand to activation; Non-gated: do not need ligandIon Channel (non-gate)
Generation of electrochemical gradient across plasma membrane i.e. Ca+gradient
regulation of signal transduction , muscle contraction and triggers secretion of digestive enzyme in to exocrine pancreastic cells i.e. Na+gradient
uptake of a.a , symport, antiport; formed membrane potential i.e. K+ gradient
formed membrane potential
Q: how does the electrochemical gradient formed?
Selective movement of Ions Create a transmembrane electric potential difference
Ligand gate Ion channel characterizations multi-subunit, transmembrane protein complexes
complex is both the receptor andion channel stimuli: chemical, stretch, voltage or light
stimulus induces conformational change to open orclose ion channel
Light gated channels respond to light; in the eyes
Mechanically gated channels respond to vibration or pressure - in the ear, touch
Ligand-gate ion channels
chemical stimuli bind to receptor and open or close ion channel stimuli can be extracellular or intracellular
EXTRACELLULAR STIMULI: (neurotransmitters) – e.g. acetylcholine, dopamine, GABA, glutamate INTRACELLULAR STIMULI: (second messengers) – e.g. IP3, cAMP, cGMP, Ca2+
NMDA receptor-Ligand gated channel
Ion-channel-linked receptors
Convert chemical signals ==> electrical signals
Extracellular ligand-gated
nicotinic ACh (muscle):
2 (embryonic),
2 (adult) nicotinic ACh (neuronal): (2-10), (2-4)
glutamate: NMDA, kainate, AMPA P2X (ATP)
5-HT
3GABA
A: (1-6), (1-4), (1-4), , , (1-3) Glycine
Many other types of transmembrane ion channels
==> Ion channels are common drug targets!
• Voltage-gated channels:
• Gating: controlled by membrane polarization/depolarization
• Selectivity: Na
+, K
+or Ca
+ions
• Intracellular ligand-gated channels:
• Ca
+controlled K
+channel
• ATP-sensitive K
+channel
• IP
3-operated Ca
+channel (in the ER
membrane)
Voltage gate ion channels
ion channel undergoes conformational change folllowing electrical stimulus this “depolarization” opens the channel
– leads to flow of Na+into cell – constitutes an “action potential”
channel re-closes
Pseudo-subunit vs. true subunit structure
Passive-Mediated Transport
• Gated vs non-gated
• Gated Non-Gated
Na
+-channel - voltage Na
+-channel Na
+-channel - chemical
K
+-channel - voltage K
+-channel K
+-channel - chemical
Cl
--channel - chemical Cl
--channel
Regulation of Ion Channels
A wide range of plasma membrane ligand and voltage sensitive ion channels exist controlling cytoplasmic levels of Na+, K+, and Ca2+. For example, acetyl choline receptor allows influx of Na+ and K+ triggering
action potential in nerve/muscle
Cytoplasmic Ca2+levels regulated via outer membrane- and ER receptors (ryanodine and IP3)
Changes in level of Ca2+are particularly dramatic (1000 fold increase) A major effector of Ca2+is calmodulin which activates myosin light chain
kinase (hence promotes contraction) and calmodulin dependent protein kinase (metabolism, transcription etc)
ATP dependent pumps rapidly transport Ca2+back to where it came from meaning the signal can be very rapidly shut off then switched on again – eg muscle contraction
Intracellular ligand-gated
leukotriene C
4-gated Ca
2+ryanodine receptor Ca
2+IP
3-gated Ca
2+IP
4-gated Ca
2+Ca
2+-gated K
+Ca
2+-gated non-
selective cation
Ca
2+-gated Cl
–cAMP cation cGMP cation cAMP chloride ATP Cl
–volume-regulated Cl
–arachidonic acid-
activated K
+Na
+-gated K
+G-protein linked receptors coupled to ion channels
• Acetylcholine (muscarinic)
• Adenosine & adenine nucleotides
• Adrenaline & noradrenaline
• Angiotensin
• Bombesin
• Bradykinin
• Calcitonin
• Cannabinoid
• Chemokine
• Cholecystokinin & gastrin
• Dopamine
• Endothelin
• Galinin
• GABA (GABAB)
• Glutamate (quisqualate)
• Histamine
• 5-Hydroxytryptamine (1,2)
• Leukotriene
• Melatonin
• Neuropeptide Y
• Neurotensin
• Odorant peptides
• Opioid peptides
• Platelet-activating factor
• Prostanoid
• Protease-activated
• Tachykinins
• Taste receptors
• VIP
• Vasopressin and oxytocin